North America

Lifestyle therapy brand Myodetox raises $2 mln from angel VCs

Toronto-based lifestyle therapy brand Myodetox has secured $2 million in financing from an undisclosed group of angel investors. Founded three years ago by CEO Scott Marcaccio and Chief Creative Officer Vinh Pham, Myodetox has developed a system of manual therapy and movement programming. Built around a personalized treatment framework, the system focuses on proactive and reactive body care, injury prevention, recovery and mobility. Myodetox, which also has an office in Vancouver, will use the round's proceeds to enter the U.S. market, beginning with a new clinic located in Los Angeles.

Alberta Enterprise, BDC commit to Builders VC's $200 mln fund

Alberta Enterprise Corp and BDC Capital have committed capital to the inaugural fund of Builders VC, a U.S. venture capital firm with an office in Calgary. The size of the commitments was not disclosed. Builders VC has reportedly targeted US$200 million for Fund I. Founded in 2016 by General Partners Jim Kim and Paul Lee, Builders VC invests in early-stage companies with technologies capable of disrupting healthcare, agriculture, industrial and real estate industries. The Calgary office is led by Partner Mark Blackwell. Builder VC's Canadian investments include Calgary-based artificial lift optimization solution Ambyint and Calgary-based capital project delivery platform Veerum.

Nasdaq buys VC-backed alternative data platform Quandl

Nasdaq has acquired Quandl Inc, a Toronto-based provider of alternative and core financial data to investment professionals. No financial terms were disclosed. Founded in 2012 by CEO Tammer Kamel and CDO Abraham Thomas, Quandl provides a database of alternative, financial and public data that is currently tapped by more than 30,000 active monthly users. Nasdaq said the acquisition will maximize its opportunities as a technology and analytics provider to capital markets. Quandl raised more than $20 million from venture capital firms, most recently in a 2016 Series B financing. Its backers included August Capital, iGan Partners and Nexus Venture Partners.

Providence Ventures backs Trilliant Health

Brentwood, Tennessee-based Trilliant Health, a healthcare analytics and growth company focused on intelligent patient acquisition for hospitals and healthcare providers, has secured additional funding from Providence Ventures. No financial terms were disclosed. Trilliant's other backers include Noro-Moseley Partners, Martin Ventures, Nashville Capital Network and NueCura Partners.

NFP Ventures funds Indio Technologies

Indio Technologies Inc., a management software platform for property and casualty insurance providers, has raised funding from NFP Ventures, an early-stage investment arm of NFP. No financial terms were disclosed.

Enzyme Health locks in $1.7 mln in Silverton-led round

Austin-based Enzyme Health, a recruiting marketplace for clinical telehealth jobs, has raised $1.7 million in seed funding. Silverton Partners led the round.

Matrix Partners leads Series A round for Fivetran

Oakland, California-based Fivetran, which is "redefining data pipelines," has raised $15 million in Series A funding. Matrix Partners led the round.

Hotel booking service SnapTravel tops up Series A to $28 mln

Toronto-based hotel booking service SnapTravel has closed its Series A financing at about $28 million (US$21.2 million). The round's US$13.2 million second tranche, which added to an initial US$8 million raised last year, was backed by Telstra Ventures, the investment arm of Australia's Telstra Corp Ltd, and NBA player Stephen Curry. Founded in 2016 by CEO Hussein Fazal and CTO Henry Shi, SnapTravel uses machine learning and natural language processing to help consumers book hotels through conversations with a travel assistant. To date, it has facilitated conversations with more than 2 million consumers in over 150 countries. The funds raised will be used by SnapTravel to enhance its technology.

ResMed to buy digital therapeutics firm Propeller Health for $225 mln

ResMed has agreed to acquire Madison, Wisconsin-based Propeller Health, a digital therapeutics company, for $225 million. DLA Piper is serving as legal counsel to ResMed on the deal. And, Allen & Company LLC is providing financial advice to Propeller while Fenwick & West LLP is serving as legal counsel. Propeller Health's backers include Aptar Pharma, Safeguard Scientifics, Social Capital, Hikma, 3M Ventures and SR One.

Ultrahaptics fetches $45 mln Series C

Ultrahaptics, a mid-air haptics technology company, has secured $45 million in Series C funding. Mayfair Equity Partners led the round with participation from other investors that included Hostplus, IP Group plc, Woodford Investment, Cornes and Dolby Family Ventures.